We are live on ! Find out more
BNTC icon

Benitec Biopharma
BNTC

56 hedge funds and large institutions have $325M invested in Benitec Biopharma in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

22% more capital invested

Capital invested by funds: $265M → $325M (+$59.4M)

1.79% more ownership

Funds ownership: 86.42% → 88.21% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2% less funds holding

Funds holding: 57 → 56 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
56
Holders Change
-1
Holders Change %
-1.75%
% of All Funds
0.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
27
Reduced
10
Closed
7
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.89M
2
Goldman Sachs
Goldman Sachs
New York
+$2.21M
3
UBS Group
UBS Group
Switzerland
+$1.05M
4
State Street
State Street
Massachusetts
+$732K
5
AIC
AWM Investment Company
New York
+$574K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$1.43M
2
Marshall Wace
Marshall Wace
United Kingdom
-$503K
3
EI
EAM Investors
California
-$442K
4
Morgan Stanley
Morgan Stanley
New York
-$232K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$207K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Suvretta Capital Management
New York
$139M – – –
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$40.7M +$114K +8,894 +0.3%
Franklin Resources
3
Franklin Resources
California
$36.3M -$1.43M -111,810 -4%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$27.7M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$13.9M +$293K +22,948 +2%
BlackRock
6
BlackRock
New York
$13.3M +$2.89M +226,825 +32%
NCM
7
Nantahala Capital Management
Connecticut
$11.8M – – –
IAM
8
Infinitum Asset Management
Florida
$7.01M – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$6.15M +$297K +23,294 +6%
SCM
10
Silverarc Capital Management
Massachusetts
$3.88M +$294K +23,033 +9%
SSA
11
Schonfeld Strategic Advisors
New York
$3.65M +$26 +2 +0%
State Street
12
State Street
Massachusetts
$3.06M +$732K +57,325 +36%
Goldman Sachs
13
Goldman Sachs
New York
$2.73M +$2.21M +173,369 +826%
AIC
14
AWM Investment Company
New York
$2.57M +$574K +45,000 +33%
Ameriprise
15
Ameriprise
Minnesota
$2.17M +$568K +44,489 +40%
Northern Trust
16
Northern Trust
Illinois
$1.83M +$54.8K +4,293 +3%
UBS Group
17
UBS Group
Switzerland
$1.4M +$1.05M +82,057 +459%
SAM
18
Simplify Asset Management
Nevada
$1.1M +$122K +9,552 +14%
ECM
19
ExodusPoint Capital Management
New York
$1.09M +$19.6K +1,533 +2%
MA
20
MYDA Advisors
New York
$982K +$101K +7,884 +13%
LPC
21
Lion Point Capital
New York
$870K – – –
Charles Schwab
22
Charles Schwab
California
$635K – – –
LP
23
Longaeva Partners
Illinois
$527K -$185K -14,460 -28%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$477K +$26.2K +2,050 +6%
Barclays
25
Barclays
United Kingdom
$299K -$72.2K -5,657 -21%
1
2 3

BNTC Hedge Fund Activity: Q3 2025 in Review

56 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma (BNTC) for Q3 2025, worth a combined $325M — up 22% from $265M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BNTC and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 27 added.

The largest buyer was BlackRock, adding an estimated $2.89M. The largest seller was Franklin Resources, cutting an estimated $1.43M.

  • 56 institutional investors held Benitec Biopharma (BNTC) as of Q3 2025, down from 57 in Q2 2025.
  • Funds reported $325M of Benitec Biopharma stock for Q3 2025, up 22% quarter-over-quarter.
  • 6 funds opened new Benitec Biopharma positions in Q3 2025 and 7 closed out, a net change of -1 holder.
  • The largest Benitec Biopharma buyer in Q3 2025 was BlackRock, an estimated $2.89M added.
  • The largest Benitec Biopharma seller in Q3 2025 was Franklin Resources, an estimated $1.43M sold.

Based on aggregated 13F filings for Q3 2025.